Planned versus provisional rotational atherectomy for severe calcified coronary lesions: Insights From the ROTATE multi‐center registry
Authors:
- Azeem LatibAzeem Latib
- Neil RupareliaNRNeil Ruparelia
- Giacomo G. BoccuzziGiacomo G. Boccuzzi
- Mauro PennacchiMPMauro Pennacchi
- Gennaro SardellaGSGennaro Sardella
- Roberto GarboRGRoberto Garbo
- Fabrizio D'AScenzoFabrizio D'AScenzo
- Claudio MorettiCMClaudio Moretti
- Marco Luciano RossiMarco Luciano Rossi
- Patrizia PresbiteroPPPatrizia Presbitero
- 17 January 2016
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 88 (6) , 881-889
Abstract
Objectives: We aimed to investigate procedural feasibility and outcomes associated with planned rotational atherectomy (RA) for severely calcified coronary lesions. Background: Limited data are available addressing the benefits of planned RA compared to provisional RA.Methods: Between 2002 and 2013, all patients with calcified lesions treated by RA were enrolled. Of these, patients treated with planned RA (358 patients) were compared to those treated with provisional RA (309 patients).Results: In‐hospital major adverse cardiovascular events (MACE) were tended to be better in the planned RA group (unadjusted OR: 0.76; 95% CI: 0.44–1.31, P = 0.32, and adjusted OR: 0.59; 95% CI: 0.33–1.05, P = 0.07). The number of pre‐dilation balloon catheters was significantly lower in the planned RA group (1.17 ± 0.60 vs. 1.47 ± 0.76, P < 0.001). Procedure time, fluoroscopy time, and contrast volume used were all significantly reduced in the planned RA group compared to the provisional RA group (procedure time; 65.2 ± 36.8min vs. 84.4 ± 43.1min, P < 0.001, fluoroscopy time; 33.1 ± 22.9min vs. 51.2 ± 29.6min, P < 0.001, and contrast volume; 232.9 ± 141.6ml vs. 302.9 ± 150.3ml, P < 0.001). The incidence of MACE at 1‐year was significantly higher amongst the unadjusted population, whereas the difference was less marked between groups after propensity‐score adjustment (unadjusted HR: 1.78; 95% CI: 1.16–2.74, P = 0.01, and adjusted HR: 1.44; 95% CI: 0.92–2.26, P = 0.11).Conclusions: Planned RA appears to be safe and was associated with a reduction in procedural and fluoroscopy times, contrast volume, and the number of pre‐dilation balloon catheters used. If there is a strong likelihood of requiring RA for the treatment of severely calcified lesions, operators should have a low threshold for adopting a planned RA strategy.Keywords
This publication has 23 references indexed in Scilit:
- High-Speed Rotational Atherectomy Before Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary LesionsJACC: Cardiovascular Interventions, 2013
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionJACC, 2011
- Usefulness of Rotational Atherectomy in Preventing Polymer Damage of Everolimus-Eluting Stent in Calcified Coronary ArteryJACC: Cardiovascular Interventions, 2011
- Rotational atherectomy for fibro‐calcific coronary artery disease in drug eluting stent era: Procedural outcomes and angiographic follow‐up resultsCatheterization and Cardiovascular Interventions, 2010
- Scanning electron microscopic analysis of different drug eluting stents after failed implantation: From nearly undamaged to major damaged polymersCatheterization and Cardiovascular Interventions, 2009
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Meta-Analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplastyJACC, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Percutaneous coronary rotational angioplasty in humans: Preliminary reportJACC, 1989
- Rotational atherectomy in atherosclerotic rabbit iliac arteriesAmerican Heart Journal, 1988